Target proteins combining with pathway enrichment analyses indicates that XTN exerts its anti-CHD effect by regulating multiple pathways including PI3K-Akt mediated cell apoptosis pathway, MAPK mediated anti-inflammatory and angiogenesis pathways and so forth. This evidence concerns the gene AKT1 and coronary artery disorder.